LDL-C Scanner

LDL-C SCANNER is a practical and immediate work tool for medical professionals, which allows you to use some of the most important algorithms in the cardiovascular area.
More and more the patient comes to the Doctor with a history of treatment and, at the same time, the question of what result is how to expect the effect of the lipid-lowering treatment offers a wide range of possible answers.
The complexity of this patient is the starting point of the LDL scanner which offers bibliographic support to the decisions of the Doctors.
In LDL SCANNER are available:
1. ESC risk cards and HEART PROJECT, for the risk of cardiovascular events, using the data usually available to the Doctor.
2. Algorithm for verifying the suspicion of intolerance to statins using the indications of the literature and a flow of evaluation of muscular symptoms and other relevant parameters.
3. Dutch Lipid Score on familial hypercholesterolemia, which uses a series of simple questions that do not require critical activities on the part of the Doctor, to assess the clinical suspicion.
4. Calculation of presumed basal cholesterol levels given the therapy in progress: The efficacy data of the therapies, coming from the "summary of product characteristics" authorized by the regulatory bodies, are applied "inversely" on the patient's lipid parameters to determine what the patient's baseline may have been in the absence of therapy.
5. Simulator of the effectiveness of cholesterol-lowering therapy: again on the basis of the data from the "summary of product characteristics" authorized by regulatory bodies, the app allows you to calculate the possible outcomes of the lipid-lowering therapies available.

LDL SCANNER is a service intended exclusively for a public of health professionals, and therefore access is prohibited to anyone who does not fall within this definition: any access occurs in violation of the will of HEALTH & LIFE and is subject to civil and criminal liability. No responsibility is assumed by HEALTH & LIFE for any inaccuracies or inaccuracies of any kind that may be published. In no case, the information published can be considered as an invitation to the use of particular pharmaceutical specialties, whoever believes they recognize common conditions in the consulted contents, must turn to their own doctor for any therapeutic decision, which is exclusively to be entrusted to the appreciation of competent professionals in the field.